• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠腺癌中配体-受体相互作用的综合分析,以鉴定肿瘤微环境氧化应激和预后模型。

Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model.

机构信息

Key Laboratory of Cancer Prevention and Therapy of Tianjin, Department of Colorectal Cancer Surgery, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300202, China.

Key Laboratory of Cancer Prevention and Therapy of Tianjin, Department of Pancreatic Cancer Surgery, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300202, China.

出版信息

Curr Med Chem. 2024;31(30):4912-4934. doi: 10.2174/0929867331666230821092346.

DOI:10.2174/0929867331666230821092346
PMID:37605402
Abstract

BACKGROUND

Single-cell technology enables a deep study on the mechanism of cancers. This work delineated the function of ligand-receptor interaction in colon adenocarcinoma (COAD), and developed a LR pairs-based prognostic model.

METHODS

For identifying important LR pairs, Single-cell RNA sequencing data of COAD was included. Unsupervised consensus clustering constructed molecular subtypes. LASSO established a prognostic model. Infiltration of 22 immune cells was evaluated by Cibersort. Enrichment score of oxidative stress related pathways was determined by SsGSEA in each patient.

RESULTS

Forty-seven LR pairs were closely associated with the prognosis of COAD. Three molecular subtypes were differentiated according to 47 LR pairs, which displayed differential clinical features and molecular features. There were significant differences in immune T cell lytic activity among different subtypes. In clust1 with poor prognosis, significantly enriched oncogenic pathways were found, especially epithelial-mesenchymal transition (EMT). Additionally, it has been found that clust3 had significantly higher immune infiltration. A prognostic model containing eight LR pairs (PDGFB-PDGFRA, FLT4-VEGFC, CSF1R-CSF1, DLL1-NOTCH4, PDGFB-LRP1, DLL1- NOTCH3, FLT4-PDGFC, and NRP2-PGF) was established, which could effectively divide samples into low-risk and high-risk groups. Significantly higher oxidative stress was found among high-risk patients.

CONCLUSIONS

This study integrated expression data and single-cell data for demonstrating the effectiveness of LR pairs in establishing the prognostic model and constructing molecular subtypes. Prognostic LR pairs may contribute to tumorigenesis and progression in COAD. The prognostic model was the potential for predicting prognosis and guiding immunotherapy for COAD patients.

摘要

背景

单细胞技术使我们能够深入研究癌症的机制。本研究描绘了配体-受体相互作用在结肠腺癌(COAD)中的功能,并建立了基于 LR 对的预后模型。

方法

纳入 COAD 的单细胞 RNA 测序数据,以鉴定重要的 LR 对。无监督共识聚类构建分子亚型。LASSO 建立预后模型。通过 Cibersort 评估 22 种免疫细胞的浸润。通过 SsGSEA 确定每个患者氧化应激相关途径的富集评分。

结果

鉴定出 47 对与 COAD 预后密切相关的 LR 对。根据 47 对 LR 对,区分出 3 个分子亚型,它们显示出不同的临床特征和分子特征。不同亚型之间的免疫 T 细胞溶解活性存在显著差异。在预后不良的 clust1 中,发现了明显富集的致癌途径,特别是上皮-间充质转化(EMT)。此外,发现 clust3 具有更高的免疫浸润。包含 8 对 LR 对(PDGFB-PDGFRA、FLT4-VEGFC、CSF1R-CSF1、DLL1-NOTCH4、PDGFB-LRP1、DLL1-NOTCH3、FLT4-PDGFC 和 NRP2-PGF)的预后模型能够有效地将样本分为低风险和高风险组。高危患者的氧化应激明显升高。

结论

本研究整合了表达数据和单细胞数据,证明了 LR 对在建立预后模型和构建分子亚型方面的有效性。预后 LR 对可能有助于 COAD 的肿瘤发生和进展。该预后模型有可能预测 COAD 患者的预后并指导免疫治疗。

相似文献

1
Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model.结直肠腺癌中配体-受体相互作用的综合分析,以鉴定肿瘤微环境氧化应激和预后模型。
Curr Med Chem. 2024;31(30):4912-4934. doi: 10.2174/0929867331666230821092346.
2
Molecular subtyping for lung adenocarcinoma and a novel prognostic model based on ligand-receptor pairs.肺腺癌的分子亚型分类和基于配体-受体对的新型预后模型。
Adv Med Sci. 2022 Sep;67(2):316-327. doi: 10.1016/j.advms.2022.08.004. Epub 2022 Aug 30.
3
To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.探讨基于三级淋巴结构相关基因的结肠癌预后特征,并揭示肿瘤微环境的特点和药物预测。
Sci Rep. 2024 Jun 12;14(1):13555. doi: 10.1038/s41598-024-64308-w.
4
Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.基于血管生成相关 lncRNAs 的结肠癌风险评分模型的建立及其预后预测价值
Curr Med Chem. 2024;31(17):2449-2466. doi: 10.2174/0109298673277243231108071620.
5
DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma.DEPDC1B:一种与结肠腺癌免疫浸润相关的新型肿瘤抑制基因。
Cancer Med. 2024 Aug;13(15):e70043. doi: 10.1002/cam4.70043.
6
An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.一个与结肠腺癌预后、免疫浸润和治疗反应相关的上皮-间充质转化相关 mRNA 特征。
Pathol Oncol Res. 2023 Feb 24;29:1611016. doi: 10.3389/pore.2023.1611016. eCollection 2023.
7
A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.一种用于预测结肠腺癌总生存期和分层亚型的成对免疫基因模型。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10813-10829. doi: 10.1007/s00432-023-04957-y. Epub 2023 Jun 14.
8
The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs.三阴性乳腺癌的分子亚型被定义,并通过对配体-受体对的综合分析构建了配体-受体对评分模型。
Front Immunol. 2022 Aug 31;13:982486. doi: 10.3389/fimmu.2022.982486. eCollection 2022.
9
Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.乳酸代谢相关 lncRNA 对:揭示结直肠腺癌患者免疫景观和介导治疗反应的预后标志物。
Front Immunol. 2022 Jul 11;13:881359. doi: 10.3389/fimmu.2022.881359. eCollection 2022.
10
Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.研究与结肠腺癌免疫相关的基因特征,使用 NFM 和 WGCNA 算法预测免疫治疗效果。
Aging (Albany NY). 2024 May 13;16(9):7596-7621. doi: 10.18632/aging.205763.

引用本文的文献

1
A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer.一种新鉴定出的上皮配体-受体相关基因特征突出了POPDC3作为非小细胞肺癌潜在治疗靶点的地位。
Cell Death Dis. 2025 Feb 19;16(1):114. doi: 10.1038/s41419-025-07410-9.